Table 3.

Scenario 2. Population affected and excess cancer due to women having their screen delayed by 3 or 5 years, depending on age.

Age group in 2020	Women affected by delay to screeninga	Estimated number of women with CIN2/3 in population	Excess diagnosis of cervical cancer	Rates per 100,000 affected (all stages)	Rates per 100,000 population (all stages)
25–29	255,660	9427b	68	26.5	3.6
30–34	221,655	3407b	51	22.9	2.7
35–39	227,561	3641	76	33.2	4.0
40–44	206,359	3302	126	61.2	7.4
45–49	219,440	3511	134	61.2	7.2
50–54	169,859	849	73	43.0	3.7
55–59	128,471	642	55	43.0	3.0
60–64	93,216	466	49	52.1	3.1
Total	1,522,219	25,246	632	41.5	4.3

^aWomen who undergo screening during a period of 6 months, estimated from the NHS Cervical Screening Programme statistics for years 2018–2019.

^bRate of CIN2/3 in the population adjusted for proportion vaccinated.